Global Recombinant Vaccine Market Research Report 2021
- Published Date: 2021-04-20
- Report ID: 103285
- Pages: 180
-
Format:
Prudent Markets Predicts that Recombinant Vaccine Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Recombinant Vaccine Market Overview:
Global Recombinant Vaccine Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Recombinant Vaccine involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Recombinant Vaccine Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Recombinant Vaccine market in 2020.
Global Recombinant Vaccine Market Segmentation
By Type, Recombinant Vaccine market has been segmented into:
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
By Application, Recombinant Vaccine market has been segmented into:
Human
Animal
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Recombinant Vaccine market are:
Merck & Co. Inc.
Green Cross Corporation
Pfizer Inc.
Sanofi S A.
Protein Science Corporation
GlaxoSmithKline Plc
Novartis AG
Bharat Biotech
1. Market Overview of Recombinant Vaccine
1.1 Recombinant Vaccine Market Overview
1.1.1 Recombinant Vaccine Product Scope
1.1.2 Market Status and Outlook
1.2 Recombinant Vaccine Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Recombinant Vaccine Historic Market Size by Regions (2015-2020)
1.4 Recombinant Vaccine Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Recombinant Vaccine Sales Market by Type (2015-2026)
2.1 Global Recombinant Vaccine Historic Market Size by Type (2015-2020)
2.2 Global Recombinant Vaccine Forecasted Market Size by Type (2021-2026)
2.3 Subunit Recombinant Vaccines
2.4 Attenuated Recombinant Vaccines
2.5 Vector Recombinant Vaccines
3. Covid-19 Impact Recombinant Vaccine Sales Market by Application (2015-2026)
3.1 Global Recombinant Vaccine Historic Market Size by Application (2015-2020)
3.2 Global Recombinant Vaccine Forecasted Market Size by Application (2021-2026)
3.3 Human
3.4 Animal
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Recombinant Vaccine Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Recombinant Vaccine Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Recombinant Vaccine Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Recombinant Vaccine Business
5.1 Merck & Co. Inc.
5.1.1 Merck & Co. Inc. Company Profile
5.1.2 Merck & Co. Inc. Recombinant Vaccine Product Specification
5.1.3 Merck & Co. Inc. Recombinant Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Green Cross Corporation
5.2.1 Green Cross Corporation Company Profile
5.2.2 Green Cross Corporation Recombinant Vaccine Product Specification
5.2.3 Green Cross Corporation Recombinant Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Pfizer Inc.
5.3.1 Pfizer Inc. Company Profile
5.3.2 Pfizer Inc. Recombinant Vaccine Product Specification
5.3.3 Pfizer Inc. Recombinant Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Sanofi S A.
5.4.1 Sanofi S A. Company Profile
5.4.2 Sanofi S A. Recombinant Vaccine Product Specification
5.4.3 Sanofi S A. Recombinant Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Protein Science Corporation
5.5.1 Protein Science Corporation Company Profile
5.5.2 Protein Science Corporation Recombinant Vaccine Product Specification
5.5.3 Protein Science Corporation Recombinant Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 GlaxoSmithKline Plc
5.6.1 GlaxoSmithKline Plc Company Profile
5.6.2 GlaxoSmithKline Plc Recombinant Vaccine Product Specification
5.6.3 GlaxoSmithKline Plc Recombinant Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Novartis AG
5.7.1 Novartis AG Company Profile
5.7.2 Novartis AG Recombinant Vaccine Product Specification
5.7.3 Novartis AG Recombinant Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Bharat Biotech
5.8.1 Bharat Biotech Company Profile
5.8.2 Bharat Biotech Recombinant Vaccine Product Specification
5.8.3 Bharat Biotech Recombinant Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Recombinant Vaccine Market Size (2015-2026)
6.2 North America Recombinant Vaccine Key Players in North America (2015-2020)
6.3 North America Recombinant Vaccine Market Size by Type (2015-2020)
6.4 North America Recombinant Vaccine Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Recombinant Vaccine Market Size (2015-2026)
7.2 East Asia Recombinant Vaccine Key Players in North America (2015-2020)
7.3 East Asia Recombinant Vaccine Market Size by Type (2015-2020)
7.4 East Asia Recombinant Vaccine Market Size by Application (2015-2020)
8. Europe
8.1 Europe Recombinant Vaccine Market Size (2015-2026)
8.2 Europe Recombinant Vaccine Key Players in North America (2015-2020)
8.3 Europe Recombinant Vaccine Market Size by Type (2015-2020)
8.4 Europe Recombinant Vaccine Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Recombinant Vaccine Market Size (2015-2026)
9.2 South Asia Recombinant Vaccine Key Players in North America (2015-2020)
9.3 South Asia Recombinant Vaccine Market Size by Type (2015-2020)
9.4 South Asia Recombinant Vaccine Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Recombinant Vaccine Market Size (2015-2026)
10.2 Southeast Asia Recombinant Vaccine Key Players in North America (2015-2020)
10.3 Southeast Asia Recombinant Vaccine Market Size by Type (2015-2020)
10.4 Southeast Asia Recombinant Vaccine Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Recombinant Vaccine Market Size (2015-2026)
11.2 Middle East Recombinant Vaccine Key Players in North America (2015-2020)
11.3 Middle East Recombinant Vaccine Market Size by Type (2015-2020)
11.4 Middle East Recombinant Vaccine Market Size by Application (2015-2020)
12. Africa
12.1 Africa Recombinant Vaccine Market Size (2015-2026)
12.2 Africa Recombinant Vaccine Key Players in North America (2015-2020)
12.3 Africa Recombinant Vaccine Market Size by Type (2015-2020)
12.4 Africa Recombinant Vaccine Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Recombinant Vaccine Market Size (2015-2026)
13.2 Oceania Recombinant Vaccine Key Players in North America (2015-2020)
13.3 Oceania Recombinant Vaccine Market Size by Type (2015-2020)
13.4 Oceania Recombinant Vaccine Market Size by Application (2015-2020)
14. South America
14.1 South America Recombinant Vaccine Market Size (2015-2026)
14.2 South America Recombinant Vaccine Key Players in North America (2015-2020)
14.3 South America Recombinant Vaccine Market Size by Type (2015-2020)
14.4 South America Recombinant Vaccine Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Recombinant Vaccine Market Size (2015-2026)
15.2 Rest of the World Recombinant Vaccine Key Players in North America (2015-2020)
15.3 Rest of the World Recombinant Vaccine Market Size by Type (2015-2020)
15.4 Rest of the World Recombinant Vaccine Market Size by Application (2015-2020)
16 Recombinant Vaccine Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
